Sigma Pharmaceuticals announced today that it again postponed its annual results for the fiscal 2009. The company said in a statement to the Australian Securities Exchange that it will release the result on or before March 31, 2010. Sigma was supposed to release the results today. Shares of the company have been in trading halt since February 25, 2010.

Sigma Pharmaceuticals, an Australian drugs maker and distributor, said that the company took the decision to delay the results because it needs some more time to finalize its accounts.  

“The board of Sigma Pharmaceuticals advises that more time than expected is required to finalize the year end 2010 accounts,” said Sue Morgan Dethick, company secretary and general counsel of Sigma, in an ASX filing.

Sources said that the reported full year profit of Sigma would be affected by adjustments including inventory provisioning, writedowns and redundancy provisioning. Reports are in the air that Sigma would take a writedown of more than $A250 million.

Investors of Sigma are reportedly eyeing on the deal with Allco Finance Group. Whereas, the board of the company has not declared whether it has taken over responsibility for any Allco related loans or liabilities which are reportedly very big and may take Sigma's net debt to more than $A500 million.

Also, there are rumors that Sigma may announce a loss of up to $A150 million while the market analysts earlier estimated full year profit of $A92 million.